Transgenic Safflower Seeds with Elevated Gamma-Linolenic Acid
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current GLA supplements derived from plant sources like evening primrose, black currant, and borage oils are costly and have low GLA concentrations, requiring high consumption for optimal health benefits, while safflower plants naturally produce negligible amounts of GLA, making them an unsuitable source for efficient GLA production.
Innovation Solution
Development of transgenic safflower plants that express Δ6-desaturase enzymes, specifically from Saprolegnia diclina, to convert linoleic acid into gamma-linolenic acid (GLA), achieving seeds and oils with GLA content of 45-60% or greater by weight, utilizing seed-specific promoters and recombinant DNA sequences.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If GLA supplements are derived from natural plant sources like evening primrose, black currant, and borage oils, then GLA can be obtained for health benefits, but the GLA concentration is low and the cost is high
Solution Approach 1:
The patent changes the genetic parameters of safflower plants by introducing Δ6-desaturase genes from Saprolegnia diclina, which fundamentally alters the fatty acid biosynthesis pathway. This genetic modification transforms safflower from a plant that naturally produces negligible GLA to one that produces 45-60% GLA in seeds, dramatically changing the concentration parameter without relying on natural plant sources
Solution Approach 2:
The patent copies the Δ6-desaturase enzyme system from Saprolegnia diclina and introduces it into safflower plants. This copying of the enzymatic pathway enables the host plant to perform GLA synthesis that it naturally lacks, achieving high GLA production through transferred genetic material rather than breeding natural variants
2Quantity of substance
If natural GLA source plants are used, then GLA supplements can be produced, but large quantities of oil must be consumed to achieve optimal health benefits
Solution Approach 1:
By modifying the genetic composition of safflower to overexpress Δ6-desaturase, the patent shifts the fatty acid profile parameter to produce 45-60% GLA. This parameter change in the source material directly reduces the quantity of oil needed to deliver therapeutic GLA doses, minimizing calorie and oil intake while maintaining health benefits
3Adaptability or versatility
If safflower plants are used as GLA source, then a commercially important crop can be utilized, but natural safflower produces negligible amounts of GLA
Solution Approach 1:
The patent fundamentally changes the metabolic parameter of safflower by introducing heterologous Δ6-desaturase genes, transforming it from a plant with negligible GLA production to one with 45-60% GLA content. This parameter change makes safflower adaptable and versatile as a commercial GLA production source while leveraging its existing agricultural advantages
Solution Approach 2:
The Δ6-desaturase enzyme from Saprolegnia diclina acts as an intermediary that bridges the gap between safflower's natural metabolic capabilities and GLA production. This intermediary enzyme catalyzes the conversion of linoleic acid to GLA, enabling safflower to produce high levels of GLA without requiring complete metabolic reprogramming
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The transgenic safflower plants significantly increase GLA production in seeds and oils, providing a cost-effective and efficient source of GLA, allowing for enhanced health benefits with reduced oil and calorie intake, and demonstrating stable and heritable GLA elevation across generations.
Implementation Method 1
GLA is synthesized from linoleic acid (LA) via the action of the enzyme delta-six desaturase (A6-desaturase)
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present invention relates to compositions and methods for preparing gamma-linoleic acid (GLA) in safflower plants, particularly from seeds of safflower. Nucleic acid sequences and constructs encoding one or more fatty acid desaturase sequences are used to generate transgenic safflower plants that contain and express one or more of these sequences and produce high levels of GLA in safflower seeds. Provided are transgenic safflower plants and seeds that produce high levels of GLA. Additionally provided are oils produced from seeds of this invention. The invention also relates to methods of treating a variety of diseases including nervous system disorders, inflammatory conditions, cancer and cardiovascular disorders using the oils of this invention.